Heartgard is generally considered safe for dogs with seizures at its standard heartworm-preventative dose. The active ingredient, ivermectin, is used at an extremely low concentration in monthly heartworm chewables, well below the levels that cause neurological problems in most dogs. That said, there are specific situations where the combination of ivermectin and a seizure-prone dog warrants extra caution.
How Ivermectin Affects the Brain
Ivermectin works by paralyzing parasites, but at high enough concentrations it can also affect mammalian brain cells. Specifically, it amplifies the activity of a brain chemical called GABA, which slows down nerve signaling. Research published in PLOS Neglected Tropical Diseases found that ivermectin can boost GABA’s effect on brain receptors by more than 400% compared to GABA acting alone. At toxic levels, this excessive suppression of nerve activity leads to symptoms like severe drowsiness, loss of coordination, tremors, and in some cases seizures.
Under normal circumstances, your dog’s brain is well protected. A protein called P-glycoprotein acts as a gatekeeper at the blood-brain barrier, actively pumping ivermectin back out before it can accumulate in brain tissue. This is why the tiny dose in Heartgard (around 6 micrograms per kilogram of body weight) doesn’t cause neurological effects in most dogs. The threshold for toxicity in a typical dog is roughly 2,000 micrograms per kilogram, more than 300 times higher than what’s in a monthly chewable.
The MDR1 Gene Factor
The biggest risk factor isn’t seizures themselves. It’s a genetic variant called MDR1 (now officially ABCB1) that some breeds carry. Dogs with this variant produce a defective version of P-glycoprotein, the gatekeeper protein that keeps drugs out of the brain. When that gatekeeper doesn’t work properly, ivermectin and other drugs can cross into the brain and build up to dangerous levels.
According to Cornell University’s College of Veterinary Medicine, dogs with the MDR1 variant can show signs of drug toxicity, including seizures, at ivermectin doses as low as 100 micrograms per kilogram. That’s still roughly 16 times higher than a standard Heartgard dose, and Cornell notes that heartworm preventatives remain safe for MDR1-sensitive dogs at low, FDA-approved dosages. But the safety margin shrinks significantly for these dogs compared to dogs without the variant.
Breeds most commonly affected by MDR1 sensitivity include Collies, Australian Shepherds, Shetland Sheepdogs, Old English Sheepdogs, and their mixes. If your seizure-prone dog is one of these breeds and hasn’t been tested for the MDR1 variant, genetic testing through a simple cheek swab can clarify the risk. This is especially worth doing if your dog’s seizures don’t have a clear diagnosis, since undetected drug sensitivity could be a contributing factor.
Seizure Medications and Drug Interactions
If your dog takes anti-seizure medication, the interaction with ivermectin is worth considering. Many seizure drugs work by enhancing GABA activity in the brain, which is the same pathway ivermectin affects at higher doses. While the amount of ivermectin in Heartgard is unlikely to meaningfully alter brain GABA levels in a dog with a functioning blood-brain barrier, the overlap in mechanism is the reason veterinary neurologists sometimes prefer alternative heartworm preventatives for dogs on seizure management plans.
Some anti-seizure medications can also affect liver enzymes that process other drugs, potentially changing how quickly ivermectin is cleared from the body. This doesn’t automatically make Heartgard dangerous, but it’s a reason to make sure your veterinarian knows every medication your dog is taking before starting or continuing any heartworm prevention.
Alternative Heartworm Preventatives
If you or your vet want to avoid ivermectin entirely, several heartworm preventatives use different active ingredients. Milbemycin oxime (the ingredient in Interceptor and Sentinel) and moxidectin (in ProHeart and Advantage Multi) are both in the same drug family as ivermectin but have somewhat different profiles. Moxidectin, for example, produces less potentiation of GABA receptor activity than ivermectin at comparable brain concentrations, which may give it a modest safety advantage for neurologically sensitive dogs.
That said, all heartworm preventatives in this drug class share the same basic mechanism and the same reliance on P-glycoprotein to stay out of the brain. No heartworm preventative is completely free of neurological considerations for dogs with MDR1 mutations. The key distinction is that all of them, including Heartgard, use doses low enough to remain within safe limits even for most MDR1-affected dogs.
What Matters for Your Dog
For the majority of dogs with seizures, Heartgard at its labeled dose does not pose a significant additional risk. The dose is simply too small to meaningfully affect brain chemistry in a dog whose blood-brain barrier is functioning normally. The dogs who face real risk are those with the MDR1 genetic variant, those accidentally given doses far above the labeled amount (such as from consuming multiple chewables), or those receiving ivermectin at the much higher doses sometimes used to treat other parasites like mange.
If your dog has idiopathic epilepsy (seizures with no identified cause) and is a breed not associated with MDR1 sensitivity, Heartgard is a reasonable choice. If your dog is a herding breed or a mixed breed with possible herding ancestry, MDR1 testing removes the guesswork. And if your dog’s seizures are poorly controlled or you simply want the most cautious approach, asking your vet about a non-ivermectin heartworm preventative is a practical option that doesn’t sacrifice protection.